Search Results

There are 80862 results for: content related to: Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi’s sarcoma (CKS): a single-arm trial (oral etoposide in CKS)

  1. SIOP 2015 Scientific Programme + Index

    Pediatric Blood & Cancer

    Volume 62, Issue S4, November 2015, Pages: S143–S418,

    Version of Record online : 9 SEP 2015, DOI: 10.1002/pbc.25715

  2. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014

    Pediatric Blood & Cancer

    Volume 61, Issue S2, December 2014, Pages: S105–S433,

    Version of Record online : 16 OCT 2014, DOI: 10.1002/pbc.25314

  3. Study to support the standardization of the prescribing, dispensing and labeling of etoposide formulations in Australia

    Asia-Pacific Journal of Clinical Oncology

    Volume 6, Issue 3, September 2010, Pages: 173–186, Christine CARRINGTON, Janet WEIR and Chau DO

    Version of Record online : 23 JUL 2010, DOI: 10.1111/j.1743-7563.2010.01317.x

  4. You have free access to this content
    Current status of etoposide in the management of small cell lung cancer

    Cancer

    Volume 67, Issue S1, 1 January 1991, Pages: 231–244, David H. Johnson, John D. Hainsworth, Kenneth R. Hande and F. Anthony Greco

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19910101)67:1+<231::AID-CNCR2820671305>3.0.CO;2-E

  5. You have free access to this content
    The clinical pharmacology of etoposide

    Cancer

    Volume 67, Issue S1, 1 January 1991, Pages: 319–329, Maurice L. Slevin

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19910101)67:1+<319::AID-CNCR2820671319>3.0.CO;2-D

  6. Carboplatin and etoposide as first-line chemotherapy in advanced epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 5, Issue 6, November/December 1995, Pages: 443–448, D.Z. Edelmann, T. Peretz, V. Barak and S.O. Anteby

    Version of Record online : 24 FEB 2002, DOI: 10.1046/j.1525-1438.1995.05060443.x

  7. You have free access to this content
    Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia

    Cancer

    Volume 77, Issue 11, 1 June 1996, Pages: 2313–2317, Sharon Shaklai, Osnat Bairey, Dorit Blickstein, Miron Prokocimer, Herzlia Hadar, Meir Lahav, Jaqueline Sulkes and Mati Shaklai

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2313::AID-CNCR20>3.0.CO;2-Z

  8. Clinical pharmacological profile of etoposide in elderly patients with lung cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 1, Issue 2-3, September 2005, Pages: 92–97, Mitsuru MIYAZAKI, Yasushiro FUJIWARA, Tetsuya OGURI, Toshiaki TAKAHASHI, Terumasa OHUNE, Hidetaka SUMIYOSHI, Nobuoki KOHNO and Merrill J EGORIN

    Version of Record online : 11 AUG 2005, DOI: 10.1111/j.1743-7563.2005.00011.x

  9. Level of evidence for therapeutic drug monitoring for etoposide after oral administration

    Fundamental & Clinical Pharmacology

    Volume 25, Issue 3, June 2011, Pages: 277–282, Pauline Gerritsen-van Schieveen, Bernard Royer and ‘Therapeutic drug monitoring group of the French Society of Pharmacology and Therapeutics’

    Version of Record online : 30 JUN 2010, DOI: 10.1111/j.1472-8206.2010.00856.x

  10. You have free access to this content
    Chronic oral etoposide

    Cancer

    Volume 67, Issue S1, 1 January 1991, Pages: 303–309, F. Anthony Greco, David H. Johnson and John D. Hainsworth

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19910101)67:1+<303::AID-CNCR2820671316>3.0.CO;2-4

  11. Active efflux kinetics of etoposide from rabbit small intestine and colon

    Biopharmaceutics & Drug Disposition

    Volume 21, Issue 3, April 2000, Pages: 83–93, Jeevan Kunta, Jiansheng Yan, Vijaya D. Makhey and Patrick J. Sinko

    Version of Record online : 9 NOV 2000, DOI: 10.1002/1099-081X(200004)21:3<83::AID-BDD220>3.0.CO;2-J

  12. A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days

    Clinical Pharmacology & Therapeutics

    Volume 57, Issue 5, May 1995, Pages: 499–507, Dana S. Thompson, F. Anthony Greco, Antonius A. Miller, Nuggehally R. Srinivas, Linus N. Igwemezie, John D. Hainsworth, Lee P. Schacter, Sanjeev Kaul, Rashmi H. Barbhaiya, George C. Garrow and Kenneth R. Hande

    Version of Record online : 17 MAY 1995, DOI: 10.1016/0009-9236(95)90034-9

  13. Pharmacokinetics and pharmacodynamics of 21-day continuous oral etoposide in pediatric patients with solid tumors

    Clinical Pharmacology & Therapeutics

    Volume 58, Issue 1, July 1995, Pages: 99–107, Daryl S. Sonnichsen, Raul C. Ribeiro, Xiaolong Luo, Prasad Mathew and Mary V. Relling

    Version of Record online : 16 JUL 1995, DOI: 10.1016/0009-9236(95)90077-2

  14. You have free access to this content
    Etoposide therapy for testicular cancer

    Cancer

    Volume 67, Issue S1, 1 January 1991, Pages: 220–224, Patrick J. Loehrer Sr

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19910101)67:1+<220::AID-CNCR2820671303>3.0.CO;2-O

  15. Etoposide pharmacokinetics and pharmacodynamics after acute and chronic exposure to cisplatin

    Clinical Pharmacology & Therapeutics

    Volume 56, Issue 5, November 1994, Pages: 503–511, Mary V Relling, Howard L McLeod, Laura C Bowman and Victor M Santana

    Version of Record online : 9 NOV 1994, DOI: 10.1038/clpt.1994.171

  16. A novel approach to prepare etoposide-loaded poly(N-vinyl caprolactam-co-methylmethacrylate) copolymeric nanoparticles and their controlled release studies

    Journal of Applied Polymer Science

    Volume 127, Issue 6, 15 March 2013, Pages: 4991–4999, Sunil Shah, Angshuman Pal, Rajiv Gude and Surekha Devi

    Version of Record online : 14 JUN 2012, DOI: 10.1002/app.38107

  17. Etoposide: A Semisynthetic Epipodophyllotoxin Chemistry, Pharmacology, Pharmacokinetics, Adverse Effects and Use as an Antineoplastic Agent

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 4, Issue 2, March-April 1984, Pages: 61–71, Joseph A. Sinkule

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1984.tb03318.x

  18. You have free access to this content
    Publications

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2229

  19. You have free access to this content
    Phase II study of oral etoposide for patients with advanced breast cancer

    Cancer

    Volume 76, Issue 12, 15 December 1995, Pages: 2485–2490, Daniel M. Atienza, Charles L. Vogel, Bruce Trock and Sandra M. Swain

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19951215)76:12<2485::AID-CNCR2820761212>3.0.CO;2-J

  20. You have free access to this content
    Phase I/II study of carboplatin and oral etoposide with granulocyte-colony stimulating factor in advanced nonsmall cell lung cancer

    Cancer

    Volume 75, Issue 7, 1 April 1995, Pages: 1578–1585, Giuseppe Frasci, Giovanni Persico, Giuseppe Perillo, Giuseppe Comella, Pasquale Comella, Mario Polverino and Giulio Menzella

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19950401)75:7<1578::AID-CNCR2820750705>3.0.CO;2-I